Researchers Submit Patent Application, "Diagnostic Assays And Kits For Detection Of Folate Receptor 1", for Approval (USPTO 20230213524).
In: Women's Health Weekly, 2023-07-28, S. 646-646
serialPeriodical
Zugriff:
"In one embodiment, the at least one antibody or antigen-binding fragment thereof specifically binds to FOLR1, wherein the antibody comprises polypeptide sequences selected from the group consisting of: (a) SEQ ID NOs: 1, 2, and 3 and SEQ ID NOs: 13, 14, and 15; (b) SEQ ID NOs: 4, 5, and 6 and SEQ ID NOs: 16, 17, and 18; (c) SEQ ID NOs: 7, 8, and 9 and SEQ ID NOs: 19, 20, and 21; (d) SEQ ID NOs: 10, 11, and 12 and SEQ ID NOs: 22, 23, and 24; and (e) variants of (a) to (d) comprising 1, 2, 3, or 4 conservative amino acid substitutions. "In one embodiment, the administered antibody comprises the FOLR1 antibody huMov19. "In one embodiment, the antibody or antigen-binding fragment thereof does not bind folate receptor 2 or folate receptor 3. [Extracted from the article]
Copyright of Women's Health Weekly is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Researchers Submit Patent Application, "Diagnostic Assays And Kits For Detection Of Folate Receptor 1", for Approval (USPTO 20230213524).
|
---|---|
Zeitschrift: | Women's Health Weekly, 2023-07-28, S. 646-646 |
Veröffentlichung: | 2023 |
Medientyp: | serialPeriodical |
ISSN: | 1078-7240 (print) |
Schlagwort: |
|
Sonstiges: |
|